Ilaprazole
- Generic Name
- Ilaprazole
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18N4O2S
- CAS Number
- 172152-36-2
- Unique Ingredient Identifier
- 776Q6XX45J
- Background
Ilaprazole has been investigated in Helicobacter Infections.
- Indication
用于治疗十二指肠溃疡及反流性食管炎。
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Il-Yang Pharm. Co., Ltd.
- Target Recruit Count
- 323
- Registration Number
- NCT02084420
- Locations
- 🇰🇷
Kangbuk Samsung Hospital, Seoul, Korea, Republic of
🇰🇷Seoul Asan hoapital, Seoul, Korea, Republic of
🇰🇷Inje Busan Paik Hospital, Busan, Korea, Republic of
Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety
Phase 1
Completed
- Conditions
- HealthyIlaprazolePharmacokineticsPharmacodynamics
- Interventions
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2013-03-28
- Lead Sponsor
- Il-Yang Pharm. Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01820143
- Locations
- 🇨🇦
MDS Pharma Services, Québec, Canada
Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2012-09-20
- Lead Sponsor
- Inje University
- Target Recruit Count
- 27
- Registration Number
- NCT01688544
- Locations
- 🇰🇷
Inje University Busan Paik Hoapital Clinical Trial Center, Busan, Korea, Republic of
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
- First Posted Date
- 2012-01-12
- Last Posted Date
- 2012-01-12
- Lead Sponsor
- Il-Yang Pharm. Co., Ltd.
- Target Recruit Count
- 292
- Registration Number
- NCT01509261
- Locations
- 🇰🇷
Local Institution, Seoul, Korea, Republic of
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
Phase 2
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- First Posted Date
- 2010-04-21
- Last Posted Date
- 2010-04-21
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT01107938
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
Phase 2
Completed
- Conditions
- Duodenal Ulcer
- Interventions
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 235
- Registration Number
- NCT00953381
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 831
- Registration Number
- NCT00471094
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath